Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma
申请人:Hemmerling Martin
公开号:US20100081692A1
公开(公告)日:2010-04-01
The invention provides 1-benzyl-4-piperidinamines of the general formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are useful in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma. The compounds are inhibitors of the CCR1 receptor.
本发明提供了一般式(I)的1-苄基-4-哌啶胺,以及其制备方法、含有它们的制药组合物和在治疗中的应用。这些化合物在治疗呼吸道疾病如慢性阻塞性肺疾病和哮喘方面非常有用。这些化合物是CCR1受体的抑制剂。